chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; Body aches; Weakness; Diarrhea; She vomited once; Fatigue; low grade fever; This is a spontaneous report from a Pfizer-sponsored program. A Contactable consumer reported for a 83-years-old female patient (grandmother) that she received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unknown date, the patient experienced fever (pyrexia) 48 hours ago, and currently the patient was having body aches (pain), weakness (asthenia), diarrhea (diarrhoea) since Saturday. She vomited once (vomiting), fatigue (fatigue), low grade fever (pyrexia) Sunday. On an unspecified date, the patient underwent lab tests and procedures which included sars-cov-2 test: negative. Therapeutic measures were taken as a result of fever (pyrexia), body aches (pain), weakness (asthenia), diarrhea (diarrhoea), she vomited once (vomiting), fatigue (fatigue) and low grade fever (pyrexia). She has been taking Tylenol every day, she has been afebrile since but she still has fatigue and some body aches The reporter wanted to know if the patient could still take the second dose tomorrow. The clinical outcome of the events was Unknown.  Information on the Batch/Lot number has been requested.  Follow-up attempts are completed. No further information is expected.
Had a lot of chills for a couple of night; Headache was uncomfortable; Throat didn't feel well, thought I may have the illness (Covid); I may have the illness; Nose was wetter than it had been; She reported that her breathing became more difficult and she could not control it.; chills; headache; This spontaneous case was reported by a physician and describes the occurrence of CHILLS (chills), HEADACHE (headache), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable) and OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced HEADACHE (headache).   On an unknown date, the patient experienced CHILLS (chills), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable), OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)), ILLNESS (I may have the illness), RHINORRHOEA (Nose was wetter than it had been) and DYSPNOEA (She reported that her breathing became more difficult and she could not control it.). The patient took Tylenol  to alleviate these symptoms.  she  took oxygen machine every 8 hours and  also took Advair inhaler     At the time of the report, CHILLS (chills), HEADACHE (headache), CHILLS (Had a lot of chills for a couple of night), HEADACHE (Headache was uncomfortable), OROPHARYNGEAL PAIN (Throat didn't feel well, thought I may have the illness (Covid)), ILLNESS (I may have the illness), RHINORRHOEA (Nose was wetter than it had been) and DYSPNOEA (She reported that her breathing became more difficult and she could not control it.) outcome was unknown. Not Provided        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Presented to the hospital on 2/12/22 with cough and SOB, previously diagnosed with COVID 1/23/22.  Had received monoclonal antibody infusion on 2/2/22.  Admitted and treated with dexamethasone, remdesivir and oxygen.  Discharged from the hospital 2/16/22.  Previously vaccinated with Janssen 5/22/21.
Allergic RXN, swelling redness within 4 hrs Txt with antihistamines
Pt recvd 3 doses of Engerix-B & was determined to be a non-responders;
Not clear if this was in fact due to vaccine, but patient developed increasing arthralgias, myalgias, nausea, vomiting with fever while camping, and presented to ED twice to receive fluids and antiemetic.  Onset of symptoms was fast, possibly following second dose of oral typhoid vaccine.  Patient presented to ID physicians office to discuss, and patient was instructed not to take remaining 2 doses in case it was an reaction to the medication.  Symptoms also similar to flu-like symptoms. Patient also received Yellow Fever vaccine at the same time as first dose of oral typhoid.
This spontaneous report was received from a pharmacist concerning to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies. On 31-MAR-2017, the patient was vaccinated with PNEUMOVAX 23 (lot # L024129 and expiration date 31-JAN-2017) for prophylaxis (dose, frequency, and route of administration were not provided) and the vaccine was expired. However, no adverse events were reported. No further information was provided. Additional information has been requested.
3-6-08 8:00 pm abd and chest itching, 3-6-08 11pm buttocks itching. 3-7-08 630  red bumps under arms, abd back and buttocks. A little heaviness breathing, but no difficulty breathing.
Groggy; shortness of breath; tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Groggy), DYSPNOEA (shortness of breath) and FATIGUE (tired) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Weight gain (Due to COVID-19).    On 23-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Groggy), DYSPNOEA (shortness of breath) and FATIGUE (tired). At the time of the report, SOMNOLENCE (Groggy), DYSPNOEA (shortness of breath) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by reporter. No treatment information was provided by reporter.   This case was linked to MOD-2021-329621 (Patient Link).
Per mom patient broke out in erythematous raised papular bumps first to the site around each injection, over the course of hours to one week the rash began to spread to thighs, up to trunk and across arms. None on face. No significant pruritis. No new lesions after 1 week, rash beginning to fade. No vesicles.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 16-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided. Concomitant medication not provided.    This case was linked to MOD-2021-014543 (Patient Link).
Injection administered to patient. After administration, we went to input documentation in and were unable to due to the fact that it stated patient had already received vaccine at another clinic.
Swollen bump that is painful at base of skull/ Swollen neck lymph node; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Lot Number: EW0175) via an unspecified route of administration in the left arm on 29Apr2021 at 12:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 02May2021, the patient experienced swollen bump that is painful at base of skull three days after shot assumed that a lymph node and swollen neck lymph node all on same side as that of shot. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of events swollen bump that is painful at base of skull three days after shot assumed it's a lymph node and swollen neck lymph node all same side as that of the shot were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Headache, pain across forehead, at back of head, down back of neck, shoulders, fever 99deg F insomnia, nausea - redness and warm at site of injection - I recommended pt to contact her physician, and with pt approval, I contacted her physician and relayed all information to his assistant.
Fever, drenching nightsweats, malaise, myalgias.  Started a few days after vaccine, but persisted for over 6 weeks with objectively documented fevers up to 102F
On January 19th started a run of svts that lasted approximately 2 .5 hours doctor advised after heart rate dropped to 39 but returned to 166. I was taken by friend to a local Hospital where it was confirmed a manuver was tried Adenosine was administered the heart stopped for 6 seconds.  I was admitted where it was determined I had a heart attack.  Troponin levels climbed to 12 where it was determined that I would need heparin until the second ablation could be performed.  The next morning after being in hospital for 1 week  that the ablation was very difficult and should I need further ablation the av node would be ablated and a pacemaker would then be needed.  I am home tired from everything I have been through.  I would tell Phizer to further check people who have had cardiac ablations and cautiouslly proceed.  My EP Dr. said that the vaccine was responsible for this.
Headache, Myalgia & Arthralgia Narrative: referred to PCP if symptoms persists, reports more pain in right side of body than left. Denies visual changes, denies slurred speech or weakness of extremities.
p/vax pt had about 3 days of flu like illness w/runny nose & cough;@ the site of inj pt devel 2 small vesicular lesions, almost like small chickenpox;
No additional clarifying statements or AE details were provided; The HCP reports that a patient was administered a dose of VARIVAX that was involved in a temperature excursion.; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions or allergies, and concomitant therapies were not reported.  On 17-FEB-2023, the patient was administered dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot #W021740, expiration date: 10-JUL-2024, for prophylaxis (route of administration and anatomical location were not provided), that was involved in a temperature excursion, at a temperature of 14.7F for a time frame of 1 hour and 3 minutes. There were no previous temperature excursion. No additional clarifying statements or adverse event (AE) details were provided.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2303USA008836: US-009507513-2303USA009070: US-009507513-2303USA008740: US-009507513-2303USA008981:
PATIENT BECAME PALE AND PASSED OUT FOR A BRIEF MOMENT AND PATIENT SPONTANEOUSLY SHOOK AWAKE WHILE SITTING IN CHAIR. UNCLE STOOD INFRONT OF HIM TO PREVENT FALLING, RN SUPERVISOR AND I CHECKED LOC PATIENT AAO AND GIVEN ORANGE JUICE AND REMAINED WITH PATIENT FOR 15 MINUTES. PATIENT INSTRUCTED TO LIE DOWN FOR ANOTHER 15 MINUTES AND VITALS CHECKED BEFORE DISCHARGE. PATIENT AMBULATION STABLE. LVN
Expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0321B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The report  was reported by  clinical supervisor . Concomitant medicine were not provided.  Treatment medicine were not provided.  It was reported Patient received vaccines post manufacture expiration dates .
COVID break through case  I received my 2nd booster shot on 05/21/2022 and my COVD symptoms started on 05/15/2022 started with sore throat. 06/16/2022 i felt worse head congested, severe head, low grade fever 99.8 , . the morning of the 06/16/2022 i tested positive. i tested 06/15/2022 negative.  on 06/17/2022 i called  urgent care they prescribed PAXLOVID . I started to take the medication on the 06/17/2022. Today 06/21/2022 i s my last day.  I am recovering  still now .
Complaint of "not feeling right" difficultly breathing, tongue swelling. Went to ER diagnosed Angioedema and Bradycardia.  Saw PCP following day and has a follow up appt. with a Cardiologist.
Immediately after vaccine pt experienced chest tightening and tingling to arms and hands. This has persisted on and off until current.
Sore left arm, redness and swelling at injection sight. Muscle pain, headache, shivering, fever (100.2) and nausea. Muscle pain lasted 4 days the rest of the symptons lasted 3 days.
Hives; Case reference number US-BN-2021-002216 is a spontaneous case report initially received from a physician via Agency (reference number USBAV21-0435) on 25-Aug-2021, and concerns a female patient of unspecified age.  The patient's medical history and concomitant medication details were not provided.  On unspecified date in May-2020, the patient was vaccinated with RabAvert (inactivated rabies virus vaccine; batch number was not provided), at unknown dose or route of administration, for unknown indication.    On unspecified date, an unknown amount of time since receiving the vaccine, (reported as "after the vaccine"), the patient experienced hives.   The outcome of the event hives was unknown.  The reporter did not provide seriousness and causality assessment for the event.  The reporter did not give consent for follow-up.  No further information was provided.; Reporter's Comments: Urticaria is listed for RabAvert per Agency. Reportedly, the patient experienced the mentioned events after (time interval not specified) vaccination with suspect vaccine, for unknown indication. At the time of the report, the outcome of the event is unknown. No information regarding patient's medical history and co-suspect and concomitant medication were provided. Based on available information causality between suspect vaccine and event is assessed as possibly related. The case is considered as non-serious.; Sender's Comments: Urticaria is listed for RabAvert per Agency. Reportedly, the patient experienced the mentioned events after (time interval not specified) vaccination with suspect vaccine, for unknown indication. At the time of the report, the outcome of the event is unknown. No information regarding patient's medical history and co-suspect and concomitant medication were provided. Based on available information causality between suspect vaccine and event is assessed as possibly related. The case is considered as non-serious.
Call received symptoms: swollen sore arm with redness and warmth. Hospitalized and given IV antibiotic therapy. Final diagnosis: Local reaction to PNEUMOVAX 23.
Information has been received from a nurse at a health department concerning a 39 year old male, who on 17-JUL-2008, was vaccinated with MMR II. On 10-AUG-2008, the patient experienced swelling of his jaw after receiving the vaccine. The patient had a history of blocked salivary glands and thought it was related to that. He went to his physician on 12-AUG-2008 and the physician said he had parotid swelling. The physician put the patient on amoxicillin in case it was related to a blocked salivary gland. The physician later told the health department nurse that he suspected a case of mumps. A mumps titer was drawn, which revealed a viral antibody of 80 for IgM and 4.41 for IgG. When the health department tried to contact the patient he was on vacation with his family. When he was seen again, the patient had already recovered (date unspecified). No product quality complaint involved. Additional information has been requested.
Within a couple hours of receiving the flumist vaccine, client experienced pain in the R upper jaw, he thought it was something related to a tooth.  Pain continued to get more intense and dental visit showed no problem with his teeth.  Pain continued to increase until it felt as though he had electric shocks in the upper R facial area.  Was diagnosed with a sinus infection , but antibiotics did not help.  Client was not sleeping and was in severe pain.  Was hospitalized for the pain and an MRI was done- diagnosed with trigeminal neuralgia and is now on Tegretol and ibuprofen.  The Tegretol has provided relief for the pain, but still has a dull ache.  12/01/08 MR received for DOS 1112-13/2008 with D/C DX:  Trigeminal Neuralgia. Pt initially presented to dentist with c/o R-sided upper teeth pain. No problems found but Rx Z-pak for possible sinus infection. Pain worsened, disturbing sleep. Pain is sharp, lancinating near R ear, cheek and eye. (+) maxillary tenderness. PE WNL except for severe pain and crying. Tx with pain meds and Tegretol with some improvement.
-pain, swelling, redness, warmth, hard lump 1/2 inch below shot site.  Rash on arm is getting bigger by the day.  Also, there is pain on my armpit that extends to almost my left breast. - I had muscle pain.  - Headache until day 2 - Feeling tired - Fever and Shivering  -Nauseous  - Upset stomach
Vomiting/ threw up; Diarrhea; Sick to her stomach; This is a spontaneous report from a contactable consumer (patient) and other health care professional. An 82-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6201, Expiry Date: unknown), via an unspecified route of administration on 22Feb2021 (at the age of 82-year-old) as a single dose for covid-19 immunisation. The patient medical history included gallbladder disorder and gallbladder operation (She was going through a bout right then with gall bladder problems that was why she said she does not know if that was the cause or if it seemed like it was gall bladder. She had been dealing with the gall bladder problems for about a year or more. She was tested again and again, and they finally said she has gall stones, and she has to have her gall bladder removed. The patient concomitant medications were not reported. On 23Feb2021 at 01:00 the patient experienced vomiting/ threw up, sick to her stomach, diarrhea. The reporter stated that the patient had the shot on Monday (22Feb2021), and everything was fine until 23Feb2021 (yesterday) afternoon she was sick to her stomach really bad and then during that night at about 23:30 or 24:00 she threw up and had diarrhea and she did not know if that was something that could be related to the vaccine. It was not on the sheet; nausea is but not diarrhea or throwing up. She asked if there had been anyone else call with these same symptoms. Right then it was not worse, it was worse last night, she was just sick to her stomach, she had diarrhea once again today. The patient underwent lab tests and procedures which included investigation: gall stones on unspecified date. The clinical outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected.
HA, Chest Tightness increased, patient felt hot, and inconsistent pulse, and felt as if she was going to pass out
nauseate; sweating; feeling like a flu; not felling well; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseate), HYPERHIDROSIS (sweating), INFLUENZA LIKE ILLNESS (feeling like a flu) and MALAISE (not felling well) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced NAUSEA (nauseate), HYPERHIDROSIS (sweating), INFLUENZA LIKE ILLNESS (feeling like a flu) and MALAISE (not felling well). At the time of the report, NAUSEA (nauseate), HYPERHIDROSIS (sweating), INFLUENZA LIKE ILLNESS (feeling like a flu) and MALAISE (not felling well) outcome was unknown.            Treatment and concomitant medications were not provided by reporter.
Itchy Hives on wrists and ankle. (Thought at first it was mosquito bites.) Later in the night a few more. Took Benadryl and hives disappeared after about 30 minutes.
no adverse effect; Varivax was administered via intramuscular instead of subcutaneous; Varivax was given 20 minutes after receiving a properly administered dose of M-M-R II; This spontaneous report was received from a pharmacist refers to a patient of unknown age. There was no information about the patient's concurrent conditions, medical history, drug reactions, allergies or concomitant medication.   On 28-AUG-2019, the patient was vaccinated at an unspecified retail location with varicella virus vaccine live (oka/merck)(VARIVAX) (Lot # S002877 expiration date not reported, but upon internal validation established as 29-JAN-2021), intramuscular instead of subcutaneous for prophylaxis (strength and dosage schedule were not reported). The reporter also stated that the vaccine was given 20 minutes after receiving a properly administered dose of measles virus vaccine live (enders-edmonston), mumps virus vaccine live (jeryl lynn), rubella virus vaccine live (wistar ra 27/3) (M-M-R II) for prophylaxis (strength, dosage schedule, route of administration, lot number and expiration date were not reported) at a different unspecified retail location. No adverse effects were reported.